177 related articles for article (PubMed ID: 28849111)
1. Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer.
Zhou J; Huang H; Tong S; Huo R
Mol Med Rep; 2017 Oct; 16(4):5235-5240. PubMed ID: 28849111
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway.
Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3261-3269. PubMed ID: 31081078
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
4. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway.
Li P; Xue WJ; Feng Y; Mao QS
Am J Transl Res; 2016; 8(8):3522-9. PubMed ID: 27648142
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
Cao Y; Xu R; Xu X; Zhou Y; Cui L; He X
Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
Lu L; Dai Z; Luo Q; Lv G
Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
[TBL] [Abstract][Full Text] [Related]
12. A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
Zhao JH; Sun JX; Song YX; Chen XW; Yang YC; Ma B; Wang J; Gao P; Wang ZN
J Cancer Res Clin Oncol; 2016 Mar; 142(3):601-9. PubMed ID: 26537802
[TBL] [Abstract][Full Text] [Related]
13. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway.
Zhang Y; Zhu M; Sun Y; Li W; Wang Y; Yu W
Oncol Res; 2019 Feb; 27(3):379-387. PubMed ID: 29523222
[TBL] [Abstract][Full Text] [Related]
15. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
16. A negative feedback loop between long noncoding RNA NBAT1 and Sox9 inhibits the malignant progression of gastric cancer cells.
Yan J; Huang W; Huang X; Xiang W; Ye C; Liu J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30287498
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.
Wang D; Gao ZM; Han LG; Xu F; Liu K; Shen Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4584-4590. PubMed ID: 29131257
[TBL] [Abstract][Full Text] [Related]
19. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer.
He X; Liu Z; Su J; Yang J; Yin D; Han L; De W; Guo R
Tumour Biol; 2016 Jul; 37(7):9503-10. PubMed ID: 26790438
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]